FDA Adverse Event Injury Summary report: N

XIENCE SKYPOINT¿

MDR report key: 18983454 · Received March 26, 2024

Report

Report Number
2024168-2024-03707
Event Type
Injury
Date Received
March 26, 2024
Date of Event
March 5, 2024
Report Date
July 1, 2024
Manufacturer
ABBOTT VASCULAR INC.
Product Code
NIQ
UDI-DI
08717648230592
PMA / PMN Number
P110019
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS NOT RETURNED FOR ANALYSIS. LOT HISTORY RECORD (LHR) AND CORRECTIVE AND PREVENTIVE ACTIONS (CAPA) REVIEWS WERE PERFORMED AND REVEALED NO INDICATION OF A PRODUCT QUALITY ISSUE. A QUERY OF THE COMPLAINT HANDLING DATABASE WAS NOT PERFORMED BECAUSE A SPECIFIC FAILURE MODE WAS NOT REPORTED AND SIMILARITY COULD NOT BE DETERMINED. THE INVESTIGATION WAS UNABLE TO DETERMINE A CONCLUSIVE CAUSE FOR THE REPORTED DIFFICULTIES; HOWEVER, THE TREATMENT APPEARS TO BE RELATED TO CIRCUMSTANCES OF THE PROCEDURE. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Additional Manufacturer Narrative · 0

THE DEVICE WAS NOT RETURNED FOR ANALYSIS. LOT HISTORY RECORD (LHR) AND CORRECTIVE AND PREVENTIVE ACTIONS (CAPA) REVIEWS WERE PERFORMED AND REVEALED NO INDICATION OF A PRODUCT QUALITY ISSUE. A QUERY OF THE COMPLAINT HANDLING DATABASE WAS NOT PERFORMED BECAUSE A SPECIFIC FAILURE MODE WAS NOT REPORTED AND SIMILARITY COULD NOT BE DETERMINED. THE INVESTIGATION WAS UNABLE TO DETERMINE A CONCLUSIVE CAUSE FOR THE REPORTED DIFFICULTIES; HOWEVER, THE TREATMENT APPEARS TO BE RELATED TO CIRCUMSTANCES OF THE PROCEDURE. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING. D1 CORRECTION: BRAND NAME UPDATED. D2A CORRECTION: COMMON DEVICE NAME UPDATED. D3 CORRECTION: NAME, ADDRESS UPDATED. D4 CORRECTION: CATALOG # UPDATED FROM 1800275-33 TO 1800275-28. D4 CORRECTION: PRIMARY UDI NUMBER UPDATED FROM (B)(4).

Additional Manufacturer Narrative · 0

MANUFACTURER'S INVESTIGATION IS STILL PENDING AT THIS TIME. RESULTS AND CONCLUSIONS WILL BE PROVIDED IN THE FINAL REPORT. B3, D6A, D6B: DATES ESTIMATED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE XIENCE SKYPOINT DRUG ELUTING STENT (DES) WAS EXPLANTED AND FAULTY/DEFECTIVE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1985988 XIENCE SKYPOINT¿ CORONARY DRUG-ELUTING STENT NIQ ABBOTT VASCULAR INC. 1800275-28 2110241 08717648230592

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Required Intervention